New Insights into Why and How Multiple Myeloma Arises
Multiple myeloma arises in immune cells called plasma cells. It is one of the most commonly diagnosed hematological malignancies...
Category: SU2C
Multiple myeloma arises in immune cells called plasma cells. It is one of the most commonly diagnosed hematological malignancies...
In 1993, Jon R. Katzenbach and Douglas K. Smith authored The Wisdom of Teams, a collection of observations and...
Pancreatic cancer is a deadly disease with a five-year survival rate of a mere 8.2 percent, according to statistics...
As we learned recently, Senator John McCain was diagnosed with glioblastoma multiforme, an aggressive form of central nervous system...
Stand Up To Cancer’s highly successful 2016 fundraising telecast will help keep up the pace of progress against cancer,...
We observe May as National Cancer Research Month to celebrate the tremendous advances that have been made in our...
AACR is the proud Scientific Partner for Stand Up To Cancer (SU2C), and for Colorectal Cancer Awareness Month, we...
Guest Post by Alan D. D’Andrea, MD, and Elizabeth M. Swisher, MD SU2C-OCRF-OCNA-NOCC Dream Team
Laura Shawver, PhD, is working to change the game for ovarian cancer.
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...